In patients with end-stage renal disease (ESRD) treated with haemodialysis or peritoneal
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …

More than half of all deaths among end stage renal disease (ESRD) patients are due to
cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction …

The first reports connecting uremic inflammation with a wasted and atherogenic phenotype
and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on …

Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease
(CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …

Background Euvolemia is an important adequacy parameter in peritoneal dialysis (PD)
patients. However, accurate tools to evaluate volume status in clinical practice and data on …

Background. N-terminal fragment of B-type natriuretic peptide (NT-proBNP) is a marker of
both fluid volume overload and myocardial damage, and it has been useful as a predictor of …

Background: The influence of type of dialysis on survival of patients with end-stage renal
disease (ESRD) is controversial. Objective: To compare risk for death among patients with …

C-reactive protein (CRP), the prototype marker of inflammation, and cardiac hypertrophy are
important prognostic indicators in dialysis patients. Residual renal function (RRF) has also …

A novel association between residual renal function and left ventricular hypertrophy in
peritoneal dialysis patients. Background Left ventricular hypertrophy (LVH) and dialysis …

Cardiovascular death is the most frequent cause of death in patients on peritoneal dialysis.
Risk factors for cardiovascular death in these patients include those that affect the general …